当前位置:首页 - 行情中心 - 华东医药(000963) - 财务分析

华东医药

(000963)

  

流通市值:755.08亿  总市值:755.98亿
流通股本:17.52亿   总股本:17.54亿

华东医药(000963)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润18.03亿元,每股收益1.03元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益2411500.65万元,未分配利润1825430.43万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产3881544.89万元,负债1470044.24万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入21,674,928,965.2110,735,787,899.8241,905,707,385.9131,477,654,750.5
营业总成本19,418,419,774.589,620,007,130.4337,493,020,210.8728,288,811,654.13
其他经营收益
营业利润2,243,373,665.841,132,257,266.344,324,737,325.93,215,352,175.02
利润总额2,193,163,350.791,104,950,943.824,301,513,879.473,133,883,552.06
净利润1,803,329,008.97913,984,183.423,494,185,631.762,562,604,257.61
每股收益
其他综合收益23,756,112.0582,044,972.47-10,256,659.9917,675,896.3
综合收益总额1,827,085,121.02996,029,155.893,483,928,971.772,580,280,153.91
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计21,636,328,948.1722,407,223,702.9721,051,790,761.2921,253,464,648.13
非流动资产:
非流动资产合计17,179,119,992.6117,039,935,979.3416,827,255,605.8616,241,789,077.47
资产总计38,815,448,940.7839,447,159,682.3137,879,046,367.1537,495,253,725.6
流动负债:
流动负债合计13,879,308,222.714,351,327,970.2413,794,235,373.0114,332,964,692.14
非流动负债:
非流动负债合计821,134,219.99533,135,114.07521,056,082.02591,790,995.49
负债合计14,700,442,442.6914,884,463,084.3114,315,291,455.0314,924,755,687.63
所有者权益(或股东权益):
归属于母公司股东权益合计23,751,917,39824,059,686,522.6223,060,051,397.3622,041,377,799.42
股东权益合计24,115,006,498.0924,562,696,59823,563,754,912.1222,570,498,037.97
负债和股东权益合计38,815,448,940.7839,447,159,682.3137,879,046,367.1537,495,253,725.6
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计23,360,782,717.9110,114,621,423.5344,970,182,586.2633,916,294,589.98
经营活动现金流出小计20,903,934,207.8110,947,350,117.4141,221,253,703.9131,409,891,781.07
经营活动产生的现金流量净额2,456,848,510.1-832,728,693.883,748,928,882.352,506,402,808.91
投资活动产生的现金流量:
投资活动现金流入小计58,162,534.1653,101,907327,006,060.47312,710,390.47
投资活动现金流出小计849,919,602.36698,941,307.412,497,277,729.471,917,166,036.95
投资活动产生的现金流量净额-791,757,068.2-645,839,400.41-2,170,271,669-1,604,455,646.48
筹资活动产生的现金流量:
筹资活动现金流入小计1,937,773,758.021,435,998,8485,250,514,515.63,886,821,367.5
筹资活动现金流出小计3,471,204,956.521,522,837,485.846,000,178,834.725,048,237,971.16
筹资活动产生的现金流量净额-1,533,431,198.5-86,838,637.84-749,664,319.12-1,161,416,603.66
汇率变动对现金及现金等价物的影响-116,843,004.4-3,115,685.5-47,001,718.4621,363,561.91
现金及现金等价物净增加额14,817,239-1,568,522,417.63781,991,175.77-238,105,879.32
期末现金及现金等价物余额5,004,968,425.683,421,628,769.054,990,151,186.683,970,054,131.59
补充资料:
现金及现金等价物的净增加额14,817,239-781,991,175.77-
最新报告期:2025-09-08
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
招商证券许菲菲2.232.492.782025-09-08
中信建投袁清慧,贺菊颖2.282.572.832025-09-07
西部证券李梦园2.262.612.912025-08-26
西南证券杜向阳2.312.482.712025-08-26
中银证券刘恩阳2.402.703.102025-08-25
TOP↑